↗️ Palantir (PLTR): The data-software company's stock rose 5% premarket after it posted higher quarterly profit and revenue. It also boosted its annual outlook. ↘️ Vertex Pharmaceuticals (VRTX): The biotechnology company said it wouldn't proceed with advanced testing of an experimental painkiller. Read More...
↗️ Palantir (PLTR): The data-software company’s stock rose 5% premarket after it posted higher quarterly profit and revenue. It also boosted its annual outlook. ↘️ Vertex Pharmaceuticals (VRTX): The biotechnology company said it wouldn’t proceed with advanced testing of an experimental painkiller.
